We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
-15.79%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$16.4B
AUM Growth
+$4.51B
(+38%)
Cap. Flow
+$7.45B
Cap. Flow
% of AUM
45.53%
Top 10 Holdings %
Top 10 Hldgs %
3.04%
Holding
4,763
New
1,229
Increased
1,758
Reduced
1,274
Closed
428
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$71M |
| 2 |
Bank of America
BAC
|
+$53.3M |
| 3 |
Marathon Petroleum
MPC
|
+$49.5M |
| 4 |
Illumina
ILMN
|
+$47.8M |
| 5 |
Nike
NKE
|
+$44.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$43.1M |
| 2 |
Zoetis
ZTS
|
+$33.2M |
| 3 |
Colgate-Palmolive
CL
|
+$25.5M |
| 4 |
Qualcomm
QCOM
|
+$23.7M |
| 5 |
FRC
First Republic Bank
FRC
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.38% |
| 2 | Technology | 14.53% |
| 3 | Consumer Discretionary | 10.24% |
| 4 | Healthcare | 9.93% |
| 5 | Industrials | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNCE
3276
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $379K | ﹤0.01% |
+90,123
| New | +$357K |
|
3277
AngloGold Ashanti
AU
$48.6B
| $378K | ﹤0.01% |
25,566
-434,113
| -94% | -$8.24M |
|
3278
CALL
UiPath
PATH
$7.95B
| $378K | ﹤0.01% |
+20,800
| New | +$389K |
|
3279
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$20B
| $378K | ﹤0.01% |
116,104
-5,500
| -5% | -$23.7K |
|
3280
BancFirst
BANF
$3.76B
| $377K | ﹤0.01% |
3,944
-1,217
| -24% | -$106K |
|
3281
Methode Electronics
MEI
$589M
| $376K | ﹤0.01% |
+10,138
| New | +$437K |
|
3282
D.R. Horton
DHI
$41B
| $375K | ﹤0.01% |
5,666
-159,277
| -97% | -$11.2M |
|
|
DHBCU
3283
DELISTED
DHB Capital Corp. Unit
DHBCU
| $375K | ﹤0.01% |
+38,213
| New | +$376K |
|
|
CTLT
3284
DELISTED
CATALENT, INC.
CTLT
| $374K | ﹤0.01% |
3,486
-14,383
| -80% | -$1.46M |
|
3285
Bausch + Lomb
BLCO
$6.04B
| $373K | ﹤0.01% |
+24,463
| New | +$396K |
|
3286
Alignment Healthcare
ALHC
$2.84B
| $372K | ﹤0.01% |
32,579
+1,658
| +5% | +$17.5K |
|
|
HDSN
3287
Hudson Technologies
HDSN
$241M
| $372K | ﹤0.01% |
49,468
-24,774
| -33% | -$204K |
|
3288
LivePerson
LPSN
$32.1M
| $372K | ﹤0.01% |
1,752
-6,105
| -78% | -$1.72M |
|
|
AVTA
3289
DELISTED
Avantax, Inc. Common Stock
AVTA
| $372K | ﹤0.01% |
20,178
-21,809
| -52% | -$397K |
|
|
MRNS
3290
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $371K | ﹤0.01% |
+76,635
| New | +$466K |
|
3291
Voyager Therapeutics
VYGR
$203M
| $370K | ﹤0.01% |
62,544
-151,640
| -71% | -$1.02M |
|
3292
Aldeyra Therapeutics
ALDX
$91.7M
| $368K | ﹤0.01% |
92,297
+78,312
| +560% | +$269K |
|
|
PARA
3293
PUT
DELISTED
Paramount Global Class B
PARA
| $368K | ﹤0.01% |
+14,900
| New | +$454K |
|
3294
PUT
VeriSign
VRSN
$26.8B
| $368K | ﹤0.01% |
+2,200
| New | +$404K |
|
3295
American Water Works
AWK
$26.5B
| $367K | ﹤0.01% |
2,464
-23,042
| -90% | -$3.51M |
|
|
HLTH
3296
DELISTED
Cue Health Inc. Common Stock
HLTH
| $366K | ﹤0.01% |
114,440
+82,657
| +260% | +$448K |
|
3297
Dragonfly Energy
DFLI
$19.2M
| $365K | ﹤0.01% |
+400
| New | +$363K |
|
|
ACCD
3298
DELISTED
Accolade Inc
ACCD
| $363K | ﹤0.01% |
49,069
-40,979
| -46% | -$358K |
|
3299
GameStop
GME
$8.58B
| $362K | ﹤0.01% |
11,856
-28,096
| -70% | -$894K |
|
3300
Strategy Inc
MSTR
$37.4B
| $361K | ﹤0.01% |
22,000
+12,770
| +138% | +$369K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2022 Portfolio in Review
As of Q2 2022, Cubist Systematic Strategies held 4,763 positions worth $16.4B, up 38% from $11.8B the previous quarter. Its ten largest holdings account for 3% of the portfolio.
Cubist Systematic Strategies deployed $7.45B of net new capital in Q2 2022, opening 1,229 new positions and adding to 1,758 existing holdings. Its largest new stake was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Verizon, an estimated $43.1M trimmed.
- Cubist Systematic Strategies's largest Q2 2022 buy was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.
- Cubist Systematic Strategies added most to American Express in Q2 2022, an estimated $71M increase.
- Cubist Systematic Strategies's biggest Q2 2022 reduction was Verizon, cutting an estimated $43.1M.
- Cubist Systematic Strategies fully exited UnitedHealth in Q2 2022, selling an estimated $17.1M.
- Cubist Systematic Strategies's ten largest holdings make up 3% of its $16.4B portfolio in Q2 2022.
- Cubist Systematic Strategies opened 1,229 new positions and closed 428 in Q2 2022.
- Cubist Systematic Strategies's portfolio value rose 38% quarter-over-quarter to $16.4B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.